Molecular medicine: Therapy by instant evolution
暂无分享，去创建一个
[1] R. Carrell,et al. Structure and variation of human α1–antitrypsin , 1982, Nature.
[2] G. Salvesen,et al. Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.
[3] P. Barr,et al. Synthesis in yeast of a functional oxidation-resistant mutant of human α1-antitrypsin , 1984, Nature.
[4] J H Lewis,et al. Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. , 1983, The New England journal of medicine.
[5] K. Nakajima,et al. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. , 1979, The Journal of biological chemistry.
[6] H. Baumann,et al. Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions , 1984, Nature.
[7] M. O. Dayhoff,et al. A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor. , 1980, Biochemical and biophysical research communications.